InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Larsen Glenn R., 董事. Director active across 2 companies, notably Anika Therapeutics, Inc.. Cumulatively, 6 disclosures have been logged. Activity tracked since 16 June 2021. The latest transaction was filed on 20 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Larsen Glenn R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
14,164 股0Common StockSEC:0001171843-25-004070:0
5,771 股0Common StockSEC:0001171843-24-003908:0
6,500 股0Common StockSEC:0001171843-23-003960:0
7,954 股0Common StockSEC:0001171843-22-004300:0
4,172 股0Common StockSEC:0001171843-21-004428:0
2,361 股Common StockSEC:0001171843-16-007718:0
6 条申报中的 6 条
About Larsen Glenn R.
Glenn R. Larsen is a Board Member at Anika Therapeutics, Inc. He contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is valuable in guiding the company's initiatives. As a board member, he ensures that Anika meets its performance and innovation objectives.
